Science Explorer Back to mapMap
Discussion
Researcher · Ionis Pharmaceuticals (United States) · United States

Frank Rigo

Frank Rigo publishes mostly in Molecular Biology, Genetics and Neurology, on topics such as RNA Research and Splicing, Neurogenetic and Muscular Disorders Research and Amyotrophic Lateral Sclerosis Research.

ORCID 0000-0001-6467-3309 OpenAlex
World rank
#33,244
of 7,710,434 ranked researchers
Rank in United States
#12,644
of 1,627,098
Works
249
Citations
21k
Citations per work
83.2
h-index
69
i10-index 147Top 1.2% in Molecular Biology
Frank Rigo

What does Frank Rigo research?

Frank Rigo's work is mostly in Biochemistry, Genetics and Molecular Biology (54%), Medicine (19%), Neuroscience (6%).

Life Sciences: 149 works · 59.8% of their workBiochemistry, Genetics and Molecular Biology: 134 works · 53.7% of their workMolecular Biology: 112 works · 45.1% of their workCancer Research: 12 works · 4.9% of their workGenetics: 9 works · 3.7% of their workNeuroscience: 15 works · 6.1% of their workCellular and Molecular Neuroscience: 15 works · 6.1% of their workEverything else: 52 works · 21.0% of their workHealth Sciences: 48 works · 19.2% of their workMedicine: 48 works · 19.2% of their workGenetics: 25 works · 10.2% of their workNeurology: 22 works · 9.0% of their workTHEIR WORKFrank Rigo249works
Life Sciences60%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology13453.7%
    2. Neuroscience156.1%
  2. Everything else5221.0%
    1. Medicine4819.2%
  1. 1Molecular Biology45% of their works
  2. 2Genetics10% of their works
  3. 3Neurology9% of their works
  4. 4Cellular and Molecular Neuroscience6% of their works
  5. 5Cancer Research5% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Frank Rigo's research?

The keywords of their largest research topics: Alternative Splicing, RNA-Binding Proteins, SMN1, Spinal Muscular Atrophy, FUS/TLS, TDP-43, m6A-seq and RNA methylation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Alternative Splicing791 topic
  2. RNA-Binding Proteins791 topic
  3. SMN1691 topic
  4. Spinal Muscular Atrophy691 topic
  5. FUS/TLS521 topic
  6. TDP-43521 topic
  7. RNA methylation511 topic
  8. m6A-seq511 topic
  9. Cancer472 topics
  10. Huntington's Disease301 topic
  11. Protein Aggregation301 topic
  12. Long Noncoding RNAs241 topic
  13. RNA Regulation241 topic
  14. ADAR Deaminases231 topic
  15. RNA Editing231 topic
  16. RNA Interference211 topic
  17. siRNA Delivery211 topic

Where does Frank Rigo work?

Frank Rigo's main affiliation in the publication record is Ionis Pharmaceuticals (United States), United States.

How many publications and citations does Frank Rigo have?

OpenAlex counts 249 works and 20,714 citations for Frank Rigo, an h-index of 69, ranking #33,244 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Frank Rigo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.